PSTX - Poseida Therapeutics GAAP EPS of -$0.27 beats by $0.12 revenue of $25M beats by $18.35M
2024-03-07 17:16:08 ET
More on Poseida Therapeutics
- Poseida Therapeutics: Non-Self CAR T Looks To Be Safe And Potentially Impactful
- Seeking Alpha’s Quant Rating on Poseida Therapeutics
- Historical earnings data for Poseida Therapeutics
- Financial information for Poseida Therapeutics